Skip to content
mesothelioma chemotherapy

Malignant mesothelioma is an insidious neoplasm arising from the mesotelial surfaces, of the pleural and peritoneal cavities, the tunica vaginalis, or the pericardium.

From a histological standpoint there are hundreds of different cancers, which are grouped into five major categories: carcinoma, sarcoma, myeloma, leukemia, and lymphoma. Most cases of cancer are carcinomas – lung cancer, colon cancer, breast cancer, skin cancer. And mesothelioma is also a carcinoma. Cancers that develop on the epithelial tissue, which is the lining of organs and cavities, are called carcinomas.

Individuals diagnosed with cancer are naturally concerned about chemotherapy agentstheir future prospects. A prognosis helps predict the probable course and outcome of a specific disease, that is, whether the patient will make a full recovery or will experience a relapse (the recurrence of cancer). More on mesothelioma prognosis.

Partnership for Prescription Assistance

As health care costs skyrocket amidst a severe, nationwide economic downturn, millions of Americans are finding it harder and harder to afford the prescription medications they need. In April of 2005, the Partnership for Prescription Assistance (PPA) program was launched in an effort to help Americans become more aware of a broad spectrum of programs that provide low to no-cost prescription medicines to eligible individuals or families.

Sponsored by an association of American pharmaceutical research companies, the PPA seeks to identify local, state, and federal prescription assistance programs while disseminating the gathered information to as many individuals and families as possible. The PPA works closely with patient advocacy organizations, physicians, pharmaceutical companies, a wide variety of health care providers (both public and private), community organizations, state and federal health care officials, and others to increase public awareness of PPA resources. More...

drug development

A Reading List for People Living With Chemotherapy

Some recommended books and websites for people undergoing chemotherapy and their families.

Off-Label Drugs for Chemotherapy

Off-label use refers to the use of an approved treatment for any purpose, or in any manner, other than what is described in the treatment's labeling.

Brown Bagging Chemotherapy Drugs

An insurance company finds an inexpensive wholesale supplier of chemotherapy drugs, has the supplier ship the drugs to pharmacies near the company's subscribers, and requires its subscribers to pick up the drugs themselves and take them to their oncologist's office in a "brown bag" for infusion.


MedlinePlus tutorial on chemotherapy

How doctors choose a chemotherapy regimen

News

 

 

Name:
Phone Number:
E-mail:
Street Address:
City, State, Zip:
Comments or
Questions:
**(Packet includes information on treatment, clinical trials, cancer links, how to access legal and financial resources, and frequently asked legal questions with answers provided by Cooper, Hart, Leggiero & Whitehead, PLLC.). By filling out the above form you consent to being contacted by Cooper, Hart, Leggiero & Whitehead regarding potentially retaining legal services.


This website is sponsored by Brad Cooper* of The Cooper, Hart, Leggiero, & Whitehead, PLLC. Cooper, Hart, Leggiero, & Whitehead is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Brad Cooper is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.

 

 

 

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline.

Advances in the systemic therapy of malignant pleural mesothelioma

Kinase Inhibitors for Mesothelioma Treatment

journal abstracts

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

The second wave in kinase cancer drugs

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma


Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.